Page last updated: 2024-10-26

disulfiram and Bone Diseases, Metabolic

disulfiram has been researched along with Bone Diseases, Metabolic in 1 studies

Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.

Research Excerpts

ExcerptRelevanceReference
"We conclude that DSF has a strong osteopenia inducing effect by impairing osteoblast survival and differentiation due to the inhibition of ALDH2 function."1.40The thiocarbamate disulphide drug, disulfiram induces osteopenia in rats by inhibition of osteoblast function due to suppression of acetaldehyde dehydrogenase activity. ( Baghel, KS; Barbhuyan, TK; Bhadauria, S; Chattopadhyay, N; China, SP; Khan, K; Mittal, M; Pal, S; Porwal, K; Rawat, T; Sanyal, S; Sharma, VL, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mittal, M1
Khan, K1
Pal, S1
Porwal, K1
China, SP1
Barbhuyan, TK1
Baghel, KS1
Rawat, T1
Sanyal, S1
Bhadauria, S1
Sharma, VL1
Chattopadhyay, N1

Other Studies

1 other study available for disulfiram and Bone Diseases, Metabolic

ArticleYear
The thiocarbamate disulphide drug, disulfiram induces osteopenia in rats by inhibition of osteoblast function due to suppression of acetaldehyde dehydrogenase activity.
    Toxicological sciences : an official journal of the Society of Toxicology, 2014, Volume: 139, Issue:1

    Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Base Sequence; Bone Diseases, Metabolic; Cell Proliferat

2014